Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney-Reference-Cited by-同舟云学术

Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney

Published:2024-07 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Tan Vivian S.,Correa Rohann J.M.,Warner Andrew,Ali Muhammad,Muacevic Alexander,Ponsky Lee,Ellis Rodney J.,Lo Simon S.,Onishi Hiroshi,Swaminath Anand,Suk Kwon Young,Morgan Scott C.,Cury Fabio L.,Teh Bin S.,Mahadevan Anand,Kaplan Irving D.,Chu William,Hannan Raquibul,Staehler Michael,Zaorsky Nicholas G.,Louie Alexander V.,Siva Shankar

Publisher

Elsevier BV

Reference33 articles.

1. Renal cell carcinoma;Hsieh;Nat Rev Dis Prim,2017

2. Epidemiology of renal cell carcinoma;Capitanio;Eur Urol,2019

3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer. Version 2.2023. 2022.

4. The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis;Correa;Eur Urol Focus,2019

5. 5-Year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney);Siva;Lancet Oncol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC);Cancers;2024-07-27

2. Functional Outcomes of Stereotactic Ablative Radiotherapy: There Is Room for Improvement;European Urology Oncology;2024-07